Skip to content

A study conducted in multiple centers across India to assess breathlessness in advanced cancer patients

Point prevalence of dyspnea, quality, and effect of Dyspnea management in ambulatory patients with advanced cancer: A Multi-center Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/10/037056
Enrollment
288
Registered
2021-10-04
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D499- Neoplasm of unspecified behavior of unspecified site

Interventions

None listed

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. to have pathologically diagnosed cancer, and have been informed of their diagnosis 2. to have an advanced clinical stage or recurrence 3. to be 18 years or older 4. to be well enough to complete the questionnaire 5. to not to be suffering from severe mental or cognitive disorder

Exclusion criteria

Exclusion criteria: 1. Patients with potential curable disease referred for early palliative care 2. Patients for whom reliable contact number or method of communication is not available

Design outcomes

Primary

MeasureTime frame
Screen for clinical dyspnea as shown on a 100-mm visual analog scale and identify the clinical prevalence of dyspneaTimepoint: day 1

Secondary

MeasureTime frame
Identify the quality of dyspnea by Cancer Dyspnea Scale (CDS)Timepoint: day 1, 3 and 7;To identify the effect of dyspnea management on daily life activities and quality of life of patients using EORTC QLQ-C15 pal.Timepoint: day 1, 3 and 7;To record the dosage of opioids/ 24 hours used to manage dyspnea in Oral Morphine Equivalents (OME) and changes in VAS -DTimepoint: day 1, 3 and 7

Countries

India

Contacts

Public ContactAnuja Damani

Tata Memorial Centre

anuja.damani@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026